CHI3L1 and metabolic dysfunction-associated steatohepatitis: The WT C57BL/6 develop NAFLD/NASH like pathology on HFD in association with enhanced Chi3L1 gene expression levels which allowed us to access the role of this gene in the pathogenesis of insulin resistance.